1/21
10:32 am
lixt
DE LA SOUL-LED “GOOD HEALTH SUMMIT” LAUNCHES FEBRUARY 19 AT MOREHOUSE COLLEGE [Yahoo! Finance]
Medium
Report
DE LA SOUL-LED “GOOD HEALTH SUMMIT” LAUNCHES FEBRUARY 19 AT MOREHOUSE COLLEGE [Yahoo! Finance]
1/21
08:00 am
lixt
DE LA SOUL-LED “GOOD HEALTH SUMMIT” LAUNCHES FEBRUARY 19 AT MOREHOUSE COLLEGE
Medium
Report
DE LA SOUL-LED “GOOD HEALTH SUMMIT” LAUNCHES FEBRUARY 19 AT MOREHOUSE COLLEGE
1/20
08:00 am
lixt
LIXTE Biotechnology Attending the DealFlow Discovery Conference, January 28-29
Medium
Report
LIXTE Biotechnology Attending the DealFlow Discovery Conference, January 28-29
1/13
08:30 am
lixt
IBN Initiates Coverage of LIXTE Biotechnology Holdings Inc.
Medium
Report
IBN Initiates Coverage of LIXTE Biotechnology Holdings Inc.
12/23
09:02 am
lixt
LIXTE and its Collaborators Expand Clear Cell Ovarian Cancer Trial [Yahoo! Finance]
Low
Report
LIXTE and its Collaborators Expand Clear Cell Ovarian Cancer Trial [Yahoo! Finance]
12/23
08:00 am
lixt
LIXTE and its Collaborators Expand Clear Cell Ovarian Cancer Trial
Low
Report
LIXTE and its Collaborators Expand Clear Cell Ovarian Cancer Trial
12/22
05:36 pm
lixt
Spartan Capital Securities, LLC Serves as Placement Agent in Lixte Biotechnology Holdings, Inc.'s $4.3 Million Registered Direct Offering [Yahoo! Finance]
Low
Report
Spartan Capital Securities, LLC Serves as Placement Agent in Lixte Biotechnology Holdings, Inc.'s $4.3 Million Registered Direct Offering [Yahoo! Finance]
12/22
04:48 pm
lixt
Spartan Capital Securities, LLC Serves as Placement Agent in Lixte Biotechnology Holdings, Inc.’s $4.3 Million Registered Direct Offering
Low
Report
Spartan Capital Securities, LLC Serves as Placement Agent in Lixte Biotechnology Holdings, Inc.’s $4.3 Million Registered Direct Offering
12/18
09:00 am
lixt
Lixte Biotechnology Holdings, Inc. Announces $4.3 Million Registered Direct Offering Priced at the Market Under Nasdaq Rules
High
Report
Lixte Biotechnology Holdings, Inc. Announces $4.3 Million Registered Direct Offering Priced at the Market Under Nasdaq Rules
11/25
08:30 am
lixt
LIXTE Biotechnology Acquires Liora Technologies’ Proprietary Proton Therapy Platform for Cancer Treatment
High
Report
LIXTE Biotechnology Acquires Liora Technologies’ Proprietary Proton Therapy Platform for Cancer Treatment